Erectile dysfunction management after failed phosphodiesterase-5-inhibitor trial: a cost-effectiveness analysis

BACKGROUND: To evaluate the cost-effectiveness of alternate erectile dysfunction (ED) management options after failed first line phosphodiesterase-5-inhibitors (PDE5-I). METHODS: An empiric, repetitive decision tree analysis model was constructed using literature review and expert clinical judgement...

Full description

Saved in:
Bibliographic Details
Published in:Transl Androl Urol
Main Authors: Moses, Rachel A., Anderson, Ross E., Kim, Jaewhan, Keihani, Sorena, Craig, James R., Myers, Jeremy B., Lenherr, Sara M., Brant, William O., Hotaling, James M.
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6732088/
https://ncbi.nlm.nih.gov/pubmed/31555563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2019.03.10
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items